This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (120)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Oncology, Other  • Radiologic Imaging  • Surgery  • Surgical Interventions  • Surgical Interventions, Other  • Ultrasonography  • Gastroenterology  • Liver/ Biliary Tract/ Pancreatic Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

A Proposed Algorithm

Anton J. Bilchik, MD, PhD; Thomas F. Wood, MD; David Allegra, MD; George J. Tsioulias, MD, DMSc; Mathew Chung, MD; D. Michael Rose, MD; Kenneth P. Ramming, MD; Donald L. Morton, MD

Arch Surg. 2000;135:657-664.

Background  Thermal ablation of unresectable hepatic tumors can be achieved by cryosurgical ablation (CSA) or radiofrequency ablation (RFA). The relative advantages and disadvantages of each technique have not yet been determined.

Hypothesis  Radiofrequency ablation of malignant hepatic neoplasms can be performed safely, but is currently limited by size. Cryosurgical ablation, while associated with higher morbidity, is more effective for larger unresectable hepatic malignant neoplasms.

Design  Retrospective analysis of prospective patient database.

Patients and Methods  Between July 1992 and September 1999, 308 patients with liver tumors not amenable to curative surgical resection were treated with CSA and/or RFA (percutaneous, laparoscopic, celiotomy). No patient had preoperative evidence of extrahepatic disease. All patients underwent laparoscopy with intraoperative ultrasound if technically possible. Both RFA and CSA were performed under ultrasound guidance. Resection, as an adjunctive procedure, was combined with ablation in certain patients.

Results  Laparoscopy identified extrahepatic disease in 12% of patients, and intraoperative hepatic ultrasound identified additional lesions in 33% of patients, despite extensive preoperative imaging. Radiofrequency ablation alone or combined with resection or CSA resulted in reduced blood loss (P<.05), thrombocytopenia (P<.05), and shorter hospital stay compared with CSA alone (P<.05). Median ablation times for lesions greater than 3 cm were 60 minutes with RFA and 15 minutes with CSA (P<.001). Local recurrence rates for lesions greater than 3 cm were also greater with RFA (38% vs 17%).

Conclusions  Laparoscopy and intraoperative ultrasound are essential in staging patients with hepatic malignant neoplasms. Radiofrequency ablation when combined with CSA reduces the morbidity of multiple freezes. Although RFA is safer than CSA and can be performed via different approaches (percutaneously, laparoscopically, or at celiotomy), it is limited by tumor size (<3 cm). Percutaneous RFA should be considered in high-risk patients or those with small local recurrences.

From the John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, Calif (Drs Bilchik, Wood, Tsioulias, Chung, Rose, and Morton), and the Century City Cancer Center, Los Angeles, Calif (Drs Bilchik, Allegra, and Ramming).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Can Surgical Research Be Ethical?
Morgenstern
SURG INNOV 2008;15:157-160.
 

Role of Intraoperative Thermoablation Combined With Resection in the Treatment of Hepatic Metastasis From Colorectal Cancer
Kornprat et al.
Arch Surg 2007;142:1087-1092.
ABSTRACT | FULL TEXT  

Intraoperative Triple Antenna Hepatic Microwave Ablation
Simon et al.
Am. J. Roentgenol. 2006;187:W333-W340.
ABSTRACT | FULL TEXT  

Liver ablation therapy
Gillams
Br. J. Radiol. 2004;77:713-723.
FULL TEXT  

Bipolar Saline-enhanced Electrode for Radiofrequency Ablation: Results of Experimental Study of in Vivo Porcine Liver
Burdio et al.
Radiology 2003;229:447-456.
ABSTRACT | FULL TEXT  

Percutaneous Ablation of Liver Tumors--Reply
Adam
Arch Surg 2003;138:809-810.
FULL TEXT  

Radiofrequency Ablation of Hepatic Tumors Adjacent to the Gallbladder: Feasibility and Safety
Chopra et al.
Am. J. Roentgenol. 2003;180:697-701.
ABSTRACT | FULL TEXT  

A Comparison of Percutaneous Cryosurgery and Percutaneous Radiofrequency for Unresectable Hepatic Malignancies
Adam et al.
Arch Surg 2002;137:1332-1339.
ABSTRACT | FULL TEXT  

Ablative therapy for liver tumours
Dick et al.
Gut 2002;50:733-739.
ABSTRACT | FULL TEXT  

Hand-Assisted Laparoscopic Liver Surgery
Antonetti et al.
Arch Surg 2002;137:407-412.
ABSTRACT | FULL TEXT  

Hepatic Radiofrequency Ablation
Iannitti et al.
Arch Surg 2002;137:422-427.
ABSTRACT | FULL TEXT  

Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation
Primrose
Gut 2002;50:1-5.
ABSTRACT | FULL TEXT  

Radiofrequency Ablation of Unresectable Hepatic Malignancies: Lessons Learned
Bilchik et al.
The Oncologist 2001;6:24-33.
ABSTRACT | FULL TEXT  

Hepatic Tumors Treated with Percutaneous Radio-frequency Ablation: CT and MR Imaging Follow-up
Dromain et al.
Radiology 2002;223:255-262.
ABSTRACT | FULL TEXT